Outcomes of a pharmacist-managed medication refill program

J Am Pharm Assoc (2003). 2013 Sep-Oct;53(5):505-12. doi: 10.1331/JAPhA.2013.13008.

Abstract

Objective: To compare the completeness of medication and blood pressure monitoring among patients requesting medication refills through the pharmacist-managed medication refill and laboratory monitoring program (MRLMP) versus usual care.

Design: Quasiexperimental study.

Setting: Kaiser Permanente Colorado between November 2011 and June 2012.

Patients: Patients requesting chronic medication prescription refills.

Intervention: Community pharmacists managed the refill authorization request (RAR) process at the intervention site. For each RAR, the pharmacist reviewed patient medication monitoring needs and ordered laboratory test(s) or a clinic visit, as needed, before approval.

Main outcome measures: For medications due for laboratory or blood pressure monitoring at the time of the RAR, the 1-month rate of attaining complete monitoring was compared between groups. Pharmacist, primary care physician (PCP), and patient satisfaction and PCP time saved also were compared.

Results: 3,797 RARs for MRLMP-eligible medications were approved in the month following MRLMP implementation in the intervention and control clinics. The intervention and control groups converted 49% and 29% of medications due for laboratory monitoring ( P < 0.001) and 56% and 33% of those due for blood pressure monitoring, respectively ( P = 0.020). The intervention group PCPs were more likely than control group PCPs to report being "very satisfied" with the RAR process (80% vs. 27%, P = 0.015) and spent fewer minutes per day on refill requests (mean 17 vs. 23, P = 0.049). The intervention group pharmacists reported higher job satisfaction (mean index score 22 vs. 18, P = 0.024), and intervention group patients reported higher satisfaction with the "readiness" of their prescription when they came to pick it up (91% vs. 80%, P = 0.004).

Conclusion: A pharmacist-managed MRLMP resulted in improved process-related outcomes. Future studies should assess clinical outcomes.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Pressure Determination / methods
  • Colorado
  • Community Pharmacy Services / organization & administration*
  • Community Pharmacy Services / statistics & numerical data
  • Drug Monitoring / methods
  • Follow-Up Studies
  • Humans
  • Job Satisfaction
  • Patient Satisfaction*
  • Pharmacists / organization & administration*
  • Prescription Drugs / administration & dosage*
  • Primary Health Care / organization & administration
  • Professional Role
  • Time Factors

Substances

  • Prescription Drugs